Impact of the COVID-19 pandemic on cytopathology services in Japan

DOI Web Site 1 References
  • SASAKI Shinya
    Department of Clinical Laboratory, Sakai City Medical Center Annual Report Working Group of the Committee for Certification of Laboratory, Japanese Society of Clinical Cytology
  • WAKASA Tomoko
    Department of Diagnostic Pathology, Kindai University Nara Hospital Annual Report Working Group of the Committee for Certification of Laboratory, Japanese Society of Clinical Cytology
  • KOYAMA Yoshinori
    Department of Clinical Laboratory, Kameda Medical Center Annual Report Working Group of the Committee for Certification of Laboratory, Japanese Society of Clinical Cytology
  • HAMAKAWA Shinji
    Department of Clinical Laboratory, Showa General Hospital Annual Report Working Group of the Committee for Certification of Laboratory, Japanese Society of Clinical Cytology
  • MIYAKE Shinji
    Department of Pathology, Tokyo Medical University Hospital Annual Report Working Group of the Committee for Certification of Laboratory, Japanese Society of Clinical Cytology
  • ARAKI Kunio
    Department of Surgery, National Hospital Organization, Matsue Medical Center Annual Report Working Group of the Committee for Certification of Laboratory, Japanese Society of Clinical Cytology
  • IKEDA Satoshi
    Department of Clinical Laboratory, Tsuchiura Kyodo General Hospital Annual Report Working Group of the Committee for Certification of Laboratory, Japanese Society of Clinical Cytology
  • NAGAO Toshitaka
    Department of Pathology, Tokyo Medical University Hospital Annual Report Working Group Pre Chairman of the Committee for Certification of Laboratory, Japanese Society of Clinical Cytology
  • HIROOKA Yasuaki
    Department of Surgery, Tottori Prefectural Central Hospital Annual Report Working Group Chairman of the Committee for Certification of Laboratory, Japanese Society of Clinical Cytology

Bibliographic Information

Other Title
  • 新型コロナウイルス感染症の細胞診への影響
  • ―Based on annual reports of accredited facilities―
  • ―日本臨床細胞学会認定施設年報集計からみた全国調査報告―

Abstract

<p>Objective : The purpose of this study was to evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on various aspects of cytology practice in Japan.</p><p>Study Design : Based on the annual reports of accredited facilities of the Japanese Society for Clinical Cytology, including hospital-based cytopathology laboratories, cancer screening facilities, and clinical laboratories, we evaluated the impact of the COVID-19 pandemic on the cytology services by comparing the number of cytology specimens, participants in conferences and workshops, and other factors in 2019 and 2020.</p><p>Results : In terms of the type of facilities, there was a noticeable decrease in the number of specimens from cancer screening facilities. In regard to the specimen source, the number of sputum, respiratory, breast, thyroid, and uterine cervical were significantly decreased. In terms of training of cytopathologists, the total number of participants in meetings decreased, but in a region, it was higher in 2020 than in 2019.</p><p>Conclusion : The results of this study demonstrated a significant decrease in the number of cytology specimens received for testing during the COVID-19 pandemic. To avoid delayed diagnosis of malignancy and the associated mortality, healthcare professionals should encourage the public to undergo cancer screenings.</p>

Journal

References(1)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top